Abstract | Several large-scale genomic studies have supported an association between cases of autism spectrum disorder and mutations in the genes SH3 and multiple ankyrin repeat domains protein 1 (SHANK1), SHANK2 and SHANK3, which encode a family of postsynaptic scaffolding proteins that are present at glutamatergic synapses in the CNS. An evaluation of human genetic data, as well as of in vitro and in vivo animal model data, may allow us to understand how disruption of SHANK scaffolding proteins affects the structure and function of neural circuits and alters behaviour.
During development and throughout life, a number of dynamic processes regulate the number, size, shape and strength of neuronal synapses. These changes occur through alterations in the molecular composition of synapses and through the chemical modification of synaptic proteins [1] [2] [3] [4] . However, sometimes, the genes encoding these synaptic proteins (such as those that encode SH3 and multiple ankyrin repeat domains protein 3 (SHANK3), neuroligin 3, neuroligin 4 or neurexin 1) carry particular mutations that result in the production of dysfunctional proteins that cannot fulfil their synaptic role. The consequences of such synaptic mutations often affect both protein structure and function, leading to synaptic and circuitry defects that may have a neurodevelopmental and neuro psychiatric impact.
Mutations in the SHANK (also known as ProSAP) family genes have been linked to syndromic and idio pathic autism spectrum disorder (ASD), as well as to other neuropsychiatric and neurodevelopmental dis orders (schizophrenia and intellectual disability) [5] [6] [7] [8] . In mice, mutations in the genes encoding SHANK fam ily proteins (SHANK1, SHANK2 and SHANK3) often result in marked behavioural phenotypes. These include an increase in repetitive routines, altered social behav iour and anxietylike phenotypes, seemingly similar to those described in some human neuro psychiatric disorders 9 . Despite great research progress in establishing links between mutations in SHANK genes and ASD, the physio logical role of SHANK proteins has, until recently, been poorly understood. Here, we review the most recent studies that help to clarify the roles of SHANK proteins at the synapse, providing insightful mechanistic links to neuropsychiatric disorders.
The SHANK protein family SHANK proteins are 'master' scaffolding proteins that tether and organize intermediate scaffolding proteins. They are located at excitatory synapses, where they are crucial for proper synaptic development and function 1, 10 . In the mouse, SHANK proteins are encoded by Shank1, Shank2 and Shank3 genes. Downstream from their tran scription start sites, all three genes have alternative pro moter options, resulting in the generation of a wide array of mRNA transcripts and protein isoforms.
SHANK3. SHANK3 (also known as ProSAP2
) is the best studied of the three SHANK protein family mem bers. The Shank3 gene is located on mouse chromosome 15E3 (human location: 22q13.3), has 22 exons and spans 60 kilobases of genomic DNA (FIG. 1) . Shank3 has mul tiple intragenic promoters (probably six) 8, 11, 12 and several alternative splicing exons (exon 11, exon 12, exon 18, exon 21 and exon 22) 12 , resulting in the possible generation of several protein isoforms (see Supplementary infor mation S1 (figure)). Besides alternative promoter usage and mRNA splicing, Shank3 gene expression is regulated by epigenetic mechanisms such as DNA methylation and histone acetylation, causing tissuespecific expression of different SHANK3 isoforms [13] [14] [15] . The full length structure of mouse SHANK3 con tains six domains for protein-protein interactions: according to information contained in the databases UniProt Knowledgebase (UniProtKb) and National Center for Biotechnology Information (NCBI) database of the National Library of Medicine at the US National Institutes of Health (see Further information). These domains comprise protein domain of unknown func tion 535 (DUF535), ankyrin repeat domain, SRC homo logy 3 (SH3) domain superfamily, postsynaptic density 12 
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Shank3
Epigenetic mechanisms
A mechanism of a stable change in gene expression that does not involve changes in DNA sequence.
protein 95 (PSD95)-discs large homologue 1-zonula occludens 1 (PDZ) domain, prolinerich region (PRO) and sterile alpha motif (SAM). The aminoterminal ankyrin repeat domain (containing six ankyrin repeats) interacts with the PSD protein SHARPIN 16 and probably binds to the cytoskeleton through an interaction with spectrin alpha chain, nonerythrocytic 1 (SPTAN1; also known as αfodrin) 17 . However, the Nterminal region that precedes the ankyrin repeat domain interacts intra molecularly with the six ankyrin repeats and probably restricts the access to binding partners such as SHARPIN and SPTAN1 (REF. 18 ). The class I PDZ domain of SHANK3 interacts with SAP90/PSD95associated pro tein 1 (SAPAP1; also known as GKAP1) 10 and the gluta mate receptor 1 (GluR1; also known as GRIA1) subunit of AMPA receptors (AMPARs) 19 , which is important for dendritic spine formation and synaptic transmis sion. The PRO domain binds to Homer 20, 21 and cort actin 10 proteins, which are important for cytoskeleton regulation, synaptic transmission and plasticity. Last, the carboxyterminal SAM domain of SHANK proteins is known to selfmultimerize 10, 22 and is required for the localization of SHANK3 and SHANK2 to the PSD 23 . Besides all the aforementioned proteins, SHANKs have a number of other interaction partners 8, [24] [25] [26] [27] . SHANK2. Shank2 (also known as ProSAP1) is the largest gene among Shank gene family members and is located on mouse chromosome 7F5 (human loca tion: 11q13.2). It has 25 exons and spans about 450 Kb of mouse genomic DNA (FIG. 1) . SHANK2 contains five domains: ankyrin repeat domain (located at the N terminus), SH3, PDZ, PRO and SAM (located at the C terminus) (FIG. 1) . There are three isoforms of SHANK2 that are produced by alternative promoter usage: SHANK2E (containing all five protein domains), SHANK2A (lacking the ankyrin repeat domain) and SHANK2C (lacking the ankyrin repeat domain and the SH3 domain) (see Supplementary information S2 (fig  ure) ). Another isoform, SHANK2B, is transcribed from the same intragenic promoter as SHANK2A but shows alternative splicing. SHANK2E is the longest isoform of SHANK2 and is the only isoform that contains the ankyrin repeat domain (which is thought to coordinate actindependent events at the apical membrane of epi thelial cells 28 ). SHANK2E owes its name to the fact that it was initially thought to be expressed only in epithe lial cells 28 ; however, recent data suggest that SHANK2E is also expressed in human and mouse brain tissue, with high expression levels in the cerebellum 29, 30 . Like SHANK3 and SHANK1, SHANK2 is a scaffolding pro tein of the PSD that interacts with multiple partners at the synapse 10, 20, 24 . SHANK1. Shank1 is located on mouse chromosome 7B4 (human location: 19q13.33), has 24 exons and spans about 50 Kb of genomic DNA (FIG. 1) . The gene contains two different promoters that can generate two differ ent protein isoforms: SHANK1A (the longest isoform, which contains ankyrin repeat domain, SH3, PDZ, PRO and SAM domains) and SHANK1B (which contains PDZ, PRO and SAM domains) (see Supplementary The schematics show the full structure of the mouse SH3 and multiple ankyrin repeat domains protein (Shank) genes and the location of intragenic promoters within these genes (in the figure, indicated by the arrows with letters in blue boxes). These structures have been drawn on the basis of the information contained at the National Center for Biotechnology Information (NCBI) database and UniProt Knowledgebase (UniProtKb). The location of the protein domains is included above their respective encoding exons (in the figure, exons are numbered and colour coded). Please note that, for the Shank2 gene, some intron sequences have been deleted for simplicity. Each intron deletion is represented by a break symbol of 10 Kb, and the size of each total deletion in Kb is indicated above the respective break. ANK, ankyrin repeat domain; DUF535, protein domain of unknown function 535; PDZ, postsynaptic density protein 95-discs large homologue 1-zonula occludens 1 domain; PRO, proline-rich region; SAM, sterile alpha motif; SH3, SRC homology 3 domain superfamily. information S3 (figure)). Besides these two tran scripts, which are produced by different promoters, Shank1 also contains alternative splicing sites that can generate different transcripts 31 . These include an iso form that lacks the Cterminal SAM domain, one that lacks the Nterminal ankyrin repeat domain and the SH3 domain, and one that does not contain ankyrin repeat domain, SH3 or SAM domains (these isoforms were originally called SHANK1B, SHANK1C and SHANK1D, respectively 31 ).
CNS expression patterns.
The expression pattern of the three members of the SHANK protein family is slightly different in the rodent brain. For example, SHANK3 is the only family member that is highly enriched at cortico striatal glutamatergic synapses 32 . Shank1 mRNA seems to be exclusively expressed in the brain 31 and is particularly enriched in the cortex, thalamus, amygdala, hippocampus (CA1 and CA3), dentate gyrus and in cer ebellar Purkinje cells 9, 33, 34 . Shank2 mRNA is enriched in the cortex, thalamus, hippocampus (CA1 and CA3), dentate gyrus and in Purkinje cells 9 . It is also expressed in the kidney and liver, at lower levels 31 . Shank3 mRNA is highly expressed in the heart and moderately expressed in the brain and spleen 31 . In the brain, Shank3 mRNA is enriched in the cortex, thalamus, striatum, hippo campus (more in CA3 than in CA1), dentate gyrus and in cerebellar granule cells 9, 35, 36 (FIG. 2a) .
The different SHANK3 protein isoforms are dif ferently expressed according to developmental stage, cell type and brain region 11, 13, 35, 37 (FIG. 2b) , suggesting the existence of isoformspecific functions. The dif ferent isoforms also present different subcellular local izations 11 . SHANK3B (an isoform lacking the PRO and SAM domains) localizes to the nucleus, whereas SHANK3A, SHANK3C and SHANK3E (isoforms con taining the PRO and SAM domains) form clusters in the cytoplasm 11 . This data thus suggest that PRO and SAM domains might be important for nuclear targeting of SHANK3 isoforms and that different subcellular local izations might contribute to the existence of isoform specific functions. An important step for future research would be the generation of isoformspecific antibod ies or probes that could enable a systematic analysis of isoformspecific binding partners and iso formspecific brain expression patterns. Understanding SHANK3 protein function from an isoformspecific perspec tive may also help to explain how different Shank3 gene mutations may result in distinct phenotypic consequences.
Links between SHANK genes and ASD Currently, 1 in 88 children in the United States is diag nosed with ASD, with the prevalence being 4-5 times greater in boys than in girls (1 in 54 boys compared with 1 in 252 girls) 38, 39 . Other genetic conditions such as fragile X syndrome, tuberous sclerosis and Down syndrome are often associated with ASD. ASD diagnosis in the DSM5 (Diagnostic and Statistical Manual of Mental Disorders, fifth edition 40 ) is defined by socialcommunication and socialinteraction deficits and narrow stereotyped, repetitive behavioural interests. These symptoms begin in early childhood and interfere with an individual's daily activities.
The biggest evidence for a genetic contribution to ASD comes from twin studies, which show 31% concordance rates for dizygotic twins and 88% for monozygotic twins 41 . ASDs are clinically heterogeneous, with symp tom severity ranging from mild social deficits with nor mal cognitive abilities to severe mental impairment and absence of language skills. Evidence points towards the involvement of a number of distinct genetic variations (including chromosomal rearrangements, copy number variations and coding sequence variants) that have been associated with many different genes 42, 43 . Despite this heterogeneity, many of the implicated genes encode syn aptic proteins that have important roles in development or functioning of brain circuits (these include SHANK3, neuroligin 3, neuroligin 4 and neurexin 1) 44, 45 . Thus, the evidence suggests that, although ASDs are aetio logically heterogeneous (and the disorder may involve polygenic, monogenic and environmental factors), synaptic dysfunc tion might well be a common underlying mechanism for a defined subset of ASDs. Higher colour intensity represents a stronger expression signal (enriched areas). This part is created using data from REFS 9,11,31-34. b | The table details the expression pattern of different SHANK3 isoforms in the mouse brain. SHANK3B is expressed throughout the brain at low levels. SHANK3A and SHANK3E are enriched in the striatum and are present in the cortex, hippocampus, thalamus and amygdala. SHANK3C and SHANKD are mainly enriched in the cerebellum. SHANK3F is not represented, as no information on its expression is currently available. Hippocampal neurons strongly express all major isoforms of SHANK3, whereas astrocytes express low levels of SHANK3A, SHANK3C, SHANK3D and SHANK3E. Isoform expression pattern is extrapolated from REF. 11 .
Ring chromosomes
Structural aberrations of chromosomes, the long and short arms of which fuse together to form a ring. Ring chromosomes can have variable size and genetic content and are often associated with large terminal deletions.
Interstitial deletions
The loss of one or more segments of DNA within a single chromosome (intra-chromosomal deletion), thereby joining genes that were previously far apart.
Unbalanced translocations
Translocations are chromosomal abnormalities that are characterized by place exchange of parts of two or more different chromosomes. Balanced translocations have no net loss or gain of any chromosomal material, whereas unbalanced translocations have unequal exchange of chromosomal material, hence resulting in loss or gain of extra genes.
SHANK genes were first implicated in neurodevel opmental disorders by studies of Phelan-McDermid syndrome (PMS), a neurodevelopmental disorder that is caused by a 22q13.3 deletion and is characterized by autisticlike behaviours, hypotonia and delayed or absent speech [46] [47] [48] . Genomic rearrangements in patients with PMS include deletions, ring chromosomes, interstitial deletions and unbalanced translocations 5, 49 . SHANK3 is deleted in nearly all reported cases of PMS 50, 51 , and its disruption is therefore thought to cause the core neu rodevelopmental and behavioural deficits that are seen in patients. Supporting the idea that core PMS symptoms are due to SHANK3 haploinsufficiency 46 , individuals carrying a ring chromosome 22 in which the SHANK3 gene is intact are phenotypically normal.
Apart from the syndromic forms of autism (such as PMS, in which SHANK3 disruption may be responsible for the core phenotype), many SHANK3 mutations have also been identified in genetic screenings of patients with ASD who have not been diagnosed with PMS [5] [6] [7] 52, 53 ( 5, 8, 12, 25, 54 . A meta analysis study found that mutations or disruptions in the SHANK gene family account for ~1% of all patients with ASD 5 . There is also a correlation between SHANK1-3 mutations and the degree of cognitive impairment: patients with SHANK3 mutations have moresevere cognitive deficits than those with SHANK1 or SHANK2 mutations 5 . Together these findings indicate that a com mon neurobiological role, shared by all SHANK gene family members, may be of relevance to ASD patho physiology and that the degree of cognitive impairment in ASD may depend on which SHANK family member is mutated. The difference in impairment severity might be explained by the expression pattern of the particu lar SHANK gene that is mutated and by the extent to which the other two remaining SHANK members can (or cannot) compensate for its loss. In addition, these findings indicate that mutations in SHANK genes are a potential monogenic cause for ASD and indicate that several SHANK mutations are of a syndromic nature and should be considered for screening in clinical prac tice 5 . Last, it is worth noting that many of the human SHANK3 mutations map to exon 21 and are associated with moderate to severe intellectual disability 5 . It is cur rently unclear how mutations in the PRO domain of exon 21 might be related to the pathophysiology. One possible explanation is that exon 21 is present in most SHANK3 isoforms; thus, mutations in this exon are likely to affect the expression and/or function of a large proportion of the SHANK3 proteins that are produced.
Given the potential importance of these genes in ASD, it is crucial to understand more about their nor mal roles at the synapse and how they are disrupted by mutations. 
Breakpoints
The specific sites of chromosomal breakage that are associated with a particular chromosomal rearrangement.
Role in synaptogenesis and function Glutamatergic synapses in the CNS are character ized by an electron dense thickening underneath the post synaptic membrane, the PSD. The PSD contains more than a thousand proteins, including membrane tethered receptors and channels (such as NMDA recep tors (NMDARs), metabotropic GluRs (mGluRs) and AMPARs), adaptor and scaffolding proteins (such as SAPAP and SHANK proteins), cytoskeletal and cell adhesion proteins (such as actin and neuroligins) and signalling molecules (such as calcium/calmodulin dependent protein kinase type II (CaMKII)). Together, these create a wide macromolecular complex 55, 56 . At the heart of the PSD lies the membraneassociated guanylate kinase (MAGUK) family, the key organizers of vertebrate CNS synapses. MAGUKs are modular proteins that are composed of multiple domains that enable protein-protein interactions, such as PDZ, SH3 and Cterminal guanylate kinase domains. MAGUK members include PSD95 (also known as SAP90 or DLG4), SAP102 (also known as DLG3), SAP97 (also known as DLG1) and PSD93 (also known as chapsyn 110 or DLG2). Together, these family members build up a dense scaffold that serves as interface between clus tered membranebound receptors, cell adhesion mole cules and the actin cytoskeleton 57 . The identification of MAGUK proteins, and the subsequent cloning of their associated proteins, has extended our comprehension of the molecular composition of the PSD 1, 57, 58 . PSD95 is probably the best characterized MAGUK protein of the PSD. It has a PDZ domain that interacts with NMDARs and a guanylate kinase domain in its C terminus that is linked to members of the SAPAP family of proteins. SAPAP proteins subsequently bind to the PDZ domain of members of the SHANK protein family. SHANK proteins then bind to the actin cytoskeleton and to Homer protein, which in turn interacts with mGluRs. Through these extended links, PSD95, SAPAP, SHANK and Homer proteins form a quaternary complex that brings together mGluR and NMDAR complexes in the PSD (FIG. 3) . This functional link between NMDARs and mGluRs is likely to facilitate crosstalk between ionotropic and metabotropic glutamate receptors 59 . On a subcellular level, SHANK proteins are located in a distal area of the PSD that extends up to 120 nm away from the postsynaptic membrane 10, 60 . Recent data suggest that there are two pools of SHANK proteins in the PSD complex: one that is closer to the postsynaptic membrane and that seems to be relatively stable and able to bind to SAPAPs, and another, more dynamic, pool that is present at a distal location and probably cannot interact with SAPAPs
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. Consistent with the roles of SHANK proteins as major scaffolding proteins in the postsynaptic site, the deletion of Shank genes in mice alters the PSD levels of several pro teins including Homer, SAPAP proteins, NMDARs and AMPARs 9, 37 . Parallel to these molecular alterations, mor phological and functional changes have also been found in several Shankmutant mice. Depending on which Shank gene is mutated and on the specific nature of the mutation, many other functional and behavioural consequences can be seen. These include impaired social behaviours, selfgrooming and synaptic plasticity defects 9, 30, 36, 37, [62] [63] [64] [65] [66] [67] [68] (for a detailed comparison between Shank1, Shank2 and Shank3-mutant mice, see REFS 8, 12) . Deletion of Shank genes also affects spine numbers and size 37, 66, 69, 70 , as well as AMPA transmission (with effects on miniature excita tory postsynaptic current (mEPSC) frequency and ampli tude being observed) 9, 36, 37, 66, 71 . The different mutant mice thus indicate an important role of SHANK proteins in regulating excitatory neurotransmission.
Owing to the strong genetic association between SHANK3 mutations and ASD (see above), many neuro biology studies have focused on this particular gene. Shank3knockout (Shank3KO) mice display reduced corticostriatal connectivity and reduced striatal mEPSC frequency in adults 9, 36, 37, 66 . This suggests that loss of Shank3 decreases the number of striatal afferents that are formed during development (resulting in a reduced number of corticostriatal synapses); however, recent electro physiological data obtained at postnatal day 14 A representation of a SH3 and multiple ankyrin repeat domains protein (SHANK) located in the postsynaptic density (PSD) is shown, with its protein-protein interaction domains illustrated. The N-terminal ankyrin repeat domain (ANK) interacts with the PSD protein SHARPIN and probably binds to the cytoskeleton through an interaction with spectrin alpha chain, non-erythrocytic 1 (SPTAN1). The PSD protein 95 (PSD95)-discs large homologue 1-zonula occludens 1 (PDZ) domain interacts with SAP90/PSD95-associated proteins (SAPAPs) and the glutamate receptor 1 (GluR1) subunit of AMPA receptors (AMPARs). SAPAPs bind to PSD95, which then interacts with NMDA receptors (NMDARs). The proline-rich domain (PRO) binds to Homer (which binds to metabotropic GluRs (mGLuRs)) and cortactin proteins (which interact with actin and are important for cytoskeleton regulation). Last, the C-terminal sterile alpha motif (SAM) of SHANK proteins is known to self-multimerize and is required for the localization of SHANK proteins to the PSD. SH3, SRC homology 3 domain superfamily.
Perineuronal nets
Aggregates of extracellular matrix molecules that embed cell bodies, axon initial segments and proximal dendrites of a subset of neurons in a mesh-like structure.
Excitation/inhibition (E/I) ratio
The relationship between synaptic excitation and inhibition, two opposing forces in terms of neurotransmission.
Multisensory integration
The neural processes that are involved in synthesizing information from cross-modal stimuli.
reveal that Shank3KO mice actually exhibit increased striatal mEPSC frequency in early development 71 . These results indicate that there is a premature increase in (and subsequent arrest of) the development of excitatory affer ents onto striatal neurons in the absence of SHANK3 (REF. 71 ). Given this reduction in basal excitatory synap tic transmission, one could mistakenly assume that there is reduced activity in the striatum of Shank3KO mice. In fact, Shank3KO mice have increased in vivo activity in the striatum 36, 71 . This striatal hyperactive profile does not seem to be due to increased intrinsic excitability of striatal neurons but rather to be a downstream conse quence of increased cortical activity 71 . The mechanism behind the cortex hyperexcitability profile in the absence of SHANK3 is currently not known.
Corroborating these in vivo mouse studies, recent in vitro data also show increased frequency of evoked fir ing in cultured neurons from Shank3KO mice 72 , as well as similar changes in cultured human neurons differenti ated from induced pluripotent stem cells that are derived from the cells of patients with PMS 72, 73 . Although these studies have focused on excitatory transmission (owing to the location of SHANK3 at excitatory synaptic sites), it is important to keep in mind that Shank3 deletion may also affect inhibitory synaptic transmission. Indeed, recent data show reduced numbers of synaptic puncta con taining parvalbumin (PV; an interneuron marker in the cortex) and compromised wisteria floribunda agglutinin containing perineuronal nets that have reduced size and intensity in the insular cortex 74 , as well as reduced PV expression in the striatum 75 . In the cortex, perineu ronal nets preferentially enwrap large PVcontaining interneurons. Therefore, when perineuronal nets are disrupted, the perisomatic inhibition of the targets of these interneurons is reduced. This indicates an imma ture or altered inhibitory circuitry in Shank3KO mice. In line with these data, a different study found that the abnormal network firing pattern that is seen in cultured cortical neurons of Shank3KO mice can be normalized by application of clonazepam, an enhancer of GABA mediated inhibitory transmission 76 . Taking a different approach 35 , it has also been shown that mice carrying a deletion in Shank3 exon 9 have an increased excitation/ inhibition (E/I) ratio in the medial prefrontal cortex (mPFC). Although these mice have decreased miniature inhibi tory postsynaptic currents (mIPSC) frequency in mPFC layer 2/3 pyramidal neurons, they display increased mIPSC frequency in hippocampus CA1 pyramidal neu rons. Together, these studies suggest a developmental arrest of neural circuits in the absence of SHANK3, with consequent disruption of optimal E/I circuitry balance 77 . Given the wide array of synaptic roles of SHANK3 that are demonstrated by these studies (ranging from scaffolding to regulating spine morphology and neuro transmission), it will be important to understand which role is the most significant with regard to ASD.
Neurobiology of SHANK proteins in ASD
As noted above, several human genetic studies have pointed towards a link between mutations in SHANK1, SHANK2 or SHANK3 and ASD 5, 78 . Although ASD neuropathology remains elusive, animal models based on mice carrying relevant genetic mutations may help us to dissect the circuit basis of behaviours that are evolution ary conserved and relevant to ASD. Several behavioural abnormalities have been reported in mice with deletions in Shank genes, some of which are considered ASDlike behaviours 9, 30, [62] [63] [64] [65] 67, 68 . Thirteen different mutant mouse lines carrying Shank3 deletions have been generated so far (TABLE 2; see Supplementary information S5 (table) ). Of these, 9 of 13 mutant lines show aberrant social behav iours (1 line has not been tested for these behaviours), and 9 of 13 display repetitive selfgrooming behaviour (TABLE 2) . Selfinjurious grooming is usually observed after complete Shank3 deletion 71 and after Shank3 PDZ targeted disruption 9, 37, 66 . A key challenge is therefore to understand how the disrupted synaptic function of SHANK3 can lead to these behavioural changes.
Social interaction requires the ability to combine sensory information with emotional and cognitive con tent 79 . Many brain areas have been implicated as part of the 'social brain' , including the mPFC, the amygdala, the anterior insula, the anterior cingulate cortex, the infe rior frontal gyrus and the superior temporal sulcus [80] [81] [82] . A recent study of the mouse insular cortex found multisensory integration deficits in Shank3mutant mice and suggested that altered GABA circuits in the insular cortex may underlie the asocial urges of these mice 74 .
Other behavioural parameters, such as ultrasonic vocalizations and learning and memory, have been evaluated in some of the different Shank3mutant lines, revealing distinct results that might be related to isoformspecific disruptions in each line (TABLE 2) . Indeed, the idea that isoformspecific disruptions will result in different phenotypic consequences (and even result in different disorders) has recently gained momentum. A recent study 66 generated two novel Shank3mutant mouse lines harbouring Shank3 mutations that are found in patients with ASD 53 and schizophrenia 83 , respectively. Both mutations are located in exon 21 of the mouse Shank3 gene, and the mutations are located only 325 nucleotides apart. The ASDlinked InsG3680 mutation has a guanine nucleotide insertion at position 3680 of Shank3 cDNA, resulting in a frameshift muta tion and the appearance of a stop codon immediately after the mutation. The schizophrenialinked R1117X mutation, on the other hand, changes arginine 1117 to a stop codon. These two mutant mouse lines exhibit both distinct and shared defects at molecular, synaptic, circuit and behavioural levels 66 . Whereas mice with the ASDlinked mutation display impaired striatal synaptic transmission at postnatal day 14 and abnormal juvenile social interactions (similar to the earlyage onset of ASD symptoms), adult mice with the schizophrenialinked mutation have profound synaptic defects in the PFC and display social dominance behaviour. Given that the ASDlinked mutation results in almost complete loss of SHANK3 (similar to a full deletion of the Shank3 gene) and that the schizophrenialinked mutation results in the generation of a truncated SHANK3 protein (which could be either partially functional or act as a dominant negative), this study provides, for the first time, some 30, 67, 68 . A recent study reveals that, besides regulating excitatory synaptic transmission in neurons 67 , SHANK1 also regulates excitatory synaptic transmission in inhibitory interneurons 86 . The study further confirms the expression of all three Shank genes in CA1 PVexpressing interneurons and suggests that, in the absence of Shank1, a shift occurs in the E/I balance of the hippocampus. As a consequence, PVexpressing interneurons receive less excitatory input and provide weaker inhibitory output onto CA1 pyramidal neurons. Interestingly, no major changes were found in CA1 inhibitory synapses in Shank2mutant mice with regard to inhibitory transmission 30 or protein markers 68 . Although the different Shank1, Shank2 and Shank3mutant mice have some distinct phenotypes at the molecular and functional level, they all feature a disrupted E/I balance that results from initial changes in excitatory synaptic transmission and composition, as well as ASDrelevant behavioural phenotypes 30, 67, 68 . Taken together, the findings from different Shankmutant mice suggest that each Shank mutation might underlie a defined subset of ASD pathology and contribute to the myriad of phenotypes that are seen in patients.
Towards the development of treatment Given the complex genomic landscape of human muta tions that are associated with ASD, animal models pose a starting point to study the neurobiology of specific muta tions and establish useful genotype-cellular phenotype correlations. The SHANK3 gene, in particular, has the advantage of having available 13 difference mice models, harbouring different Shank3 gene disruptions. The gene itself is probably also less complicated to study than some other ASDrelated genes because of the defined locali zation of SHANK3 protein at glutamatergic synapses. This has advantages over the study of a transcription factor, such as methylCpGbinding protein 2 (MeCP2), which may directly regulate the expression of hundreds of genes. Because ASDs are neurodevelopmental disor ders (patients typically display symptoms before the age of three) 90, 91 , one of the key questions in autism research is whether the pathology is reversible in adults. Recently, this question was tackled in a study that generated a Shank3 conditional knockin mouse 37 . These mice are born as Shank3KO (carrying a PDZ domain dele tion) but have a FLExed PDZ domain inverted, which allows reorientation at any time point in life to restore the Shank3 gene. This strategy design is crucial because it keeps the Shank3 gene under the control of its endo genous genomic locus and avoids SHANK3 expression at nonphysiological levels that could induce potential confounds. These Shank3KO mice have deficits in stri atal neurotransmission, reduced spine density in the striatum and reduced levels of PSD proteins (SAPAP3, Homer, GluN2A, GluN2B and GluR2) in the striatum. All these alterations can be reverted in the adult by restor ing the Shank3 gene. Behaviourally, these Shank3KO 92 . More importantly, this study suggests the possibility of treatment (whether pharma cological or through future genetic repair approaches) for patients with SHANK3 mutations or deletion, during adulthood. Similar encouraging adultrescue results have been reported for mutant mice carrying deletions and duplications in other ASDrelated genes such as Mecp2 and ubiquitinprotein ligase E3A (Ube3a) 96 . Other studies have taken a different approach towards reversing the phenotype resulting from SHANK3 deficiency. In one study 97 , the phosphoproteome of SHANK3deficient rat cortical neurons was character ized, revealing an upregulation of CDClike kinase 2 (CLK2) expression. Inhibition of CLK2 rescued social behaviour in mice carrying a mutation in Shank3 exon 21, as well as synaptic deficits in SHANK3deficient neurons and neurons derived from patient with PMS.
Together, these studies suggest that adult restoration of SHANK3 levels or restoration of downstream medi ators may be a useful approach to alleviate some of the synaptic and behavioural impairments that are associ ated with SHANK3 mutations. Aligned with the idea of targeting downstream mediators and proteins associated with SHANK3 network, two groups have recently looked into mGluR5 and Homer as potential therapeutic targets in ASD. Using a complete Shank3KO mouse 36 , it was shown that antagonism of mGluR5 activity ameliorates overgrooming behaviour, whereas positive allosteric modulation of mGluR5 exacerbates selfgrooming. In a second study 98 , it was reported that a pharmacological increase in mGluR5 activity ameliorates overgrooming behaviour and rescues other behavioural deficits in Shank3KO mouse. Although these studies might, at first, seem to be discrepant -the mGlu5R positive ago nist CDPPB exacerbates and ameliorates selfgrooming in the respective studies -it is crucial to note that these results were derived from different Shank3mutant mouse lines. Furthermore, the results of the two studies were otherwise in agreement. In one study, CDPPB treatment slightly improved instrumental learning, normalized striatal longterm depression and slightly increased the protein level of two splice variants of Homer (Homer 1b and Homer 1c) in the striatum of complete Shank3KO mouse 36 . Similarly, in the other study 98 , a pharmacolog ical increase in mGluR5 activity ameliorated functional deficits (NMDAinduced membrane depolarization) and behavioural defects (social interaction and Morris water maze performance) in mice with deleted exon 11. Nevertheless, these studies suggest that the defects in downstream signalling, and thus potential therapeutic targets (such as mGluR5 and Homer), that result from dif ferent mutations of the same gene might be very different.
In an unrelated study 99 , the authors reported a marked loss of cortical actin filaments in mice with deleted exon 11, which was associated with reduced RAC1 and PAK activity and increased cofilin activity (the major actin depolymerizing factor). This suggested that actin regulators might be another potential molecular target for the treatment of ASD. Elevation of RAC1 activity in the PFC of these mice rescued their social behaviour defi cits and NMDAR hypofunction, whereas inhibition of PAK or RAC1 function induced social behaviour deficits and NMDAR hypofunction in wildtype mice.
The aforementioned demonstrations of pharmaco logical reversals of phenotypes in Shank3mutant mice highlight potential target pathways that seem to con verge with some pharmacological reversal studies car ried out in Shank2mutant mice. In those studies 68, 100 , NMDA hypofunction was suggested to be a potential mechanism underlying ASDlike behaviours. By treating Shank2mutant mice with dcycloserine (a partial ago nist of NMDAR), one study showed an improvement in social interaction that could also be attained by treating the mice with CDPPB (possibly because of the enhance ment of NMDAR function through mGluR5 activation) 68 . Similarly, another study used clioquinol (a zinc chelator and ionophore) to rescue socialinteraction deficits in Shank2mutant mice. It was suggested that clioquinol can be used to mobilize zinc towards postsynaptic sites, where it would then increase NMDAR function through tyros ine kinase SRC activation 100 . Alterations in NMDAR func tion and excitatory transmission could potentially lead to an E/I imbalance, as was also suggested by a recent study that showed impaired GABAergic neurotransmission in mice with deleted exon 6 and exon 7 (REF. 88 ). The study further demonstrated that administration of a GABA A receptor agonist can slightly improve the spatial memory deficits observed in Shank2mutant mice, although the socialinteraction deficits cannot be rescued. Together these studies suggest that NMDAR hypofunction con tributes to the development of some ASDlike phenotypes in Shankmutant mice and that other related molecular targets could potentially be used to modulate NMDAR function and improve specific phenotypes.
Conclusions and future perspectives
Many important questions remain. Can we mitigate the loss of a missing SHANK protein by somehow upregu lating other SHANK protein family members? Which of the domains of SHANK proteins are essential for their roles? Which cell types are more vulnerable to SHANK protein loss?
